Home » Topics » Disease categories and therapies » Musculoskeletal

Musculoskeletal
RSS

Resunab demonstrates clinical benefit in phase II trial in systemic sclerosis

Nov. 16, 2016

FDA awards orphan drug designation to ECCS-50 for scleroderma

Nov. 15, 2016

Medshine Discovery presents JAK2 inhibitors

Nov. 14, 2016

Mabion signs development and commercialization agreement with Mylan for Mabion-CD20

Nov. 10, 2016

ReVance Therapeutics initiates phase II trial of RT-002 in plantar fasciitis

Nov. 4, 2016

Mitsubishi Tanabe and Kolon Life Science sign licensing agreement for Invossa in Japan

Nov. 2, 2016

Flexion Therapeutics reports positive results from study of Zilretta in OA patients with diabetes

Nov. 2, 2016

AbbVie discloses TNF-alpha modulators

Nov. 2, 2016

AbbVie discloses novel TNF-alpha modulators

Oct. 31, 2016

FDA issues complete response letter for sarilumab for rheumatoid arthritis

Oct. 31, 2016

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 24, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 21, 2026
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
At AACR: Epigenetic fingerprints in metastases track tumor origin
BioWorld
When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...
AACR 2026: The age of agentic AI in oncology
BioWorld Science
New Approach Methodologies (NAMs) for drug development are transforming biomedical research by replacing or complementing animal models. More than 90% of...